SCOPE Summit 2027
Panel SCOPE Biotech Forum track
Trial Oversight and Governance in Lean ClinOps Environments
Tue, Mar 2, 2027 · 12:20–12:45 PM EST Rosen Shingle Creek
About this session
Moving from earlier-phase studies to a Phase 3 program is a major inflection point for small- and mid-sized sponsors. This panel explores how lean sponsor teams can maintain oversight as complexity scales, including building governance structures sized for limited headcount, setting vendors up to deliver right the first time, and the contract provisions sponsors should hold their CROs to for visibility into third-party vendor management.
